drugset / Trial / NCT00621296

Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C

NCT00621296

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the efficacy and safety after administration of MP-424 to patients with chronic hepatitis C.

Timeline

Start
2008-01
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Telaprevir Small molecule 750 mg Oral